Akero Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | -1K | -1K | 0 |
| R&D Expenses | 78.9M | 69.3M | 69.6M | 69.3M | 72.2M | 55.3M | 50.6M | 53.4M |
| Operating Expenses | 90.2M | 80.9M | 80.9M | 78.0M | 81.7M | 65.7M | 60.0M | 61.9M |
| Operating Income | -90.2M | -80.9M | -80.9M | -78.0M | -81.7M | -65.7M | -60.0M | -61.9M |
| Other Income / Gains | 8.7M | 10.4M | 10.2M | 8.0M | 9.0M | 9.8M | 6.6M | 6.7M |
| Net Income | -81.6M | -70.5M | -70.7M | -70.0M | -72.7M | -56.0M | -53.3M | -55.2M |
| EPS (Diluted) | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 | -0.81 | -0.90 | -0.99 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 11.4M | 11.6M | 11.3M | 8.7M | 9.5M | 10.4M | 9.3M | 8.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | -1K | -1K | 0 |
| Selling General And Administrative Expenses | 11.4M | 11.6M | 11.3M | 8.7M | 9.5M | 10.4M | 9.3M | 8.5M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 90.2M | 80.9M | 80.9M | 78.0M | 81.7M | 65.7M | 60.0M | 61.9M |
| Interest Income | 0 | 11.5M | 11.3M | 9.2M | 10.2M | 11.0M | 7.6M | 7.6M |
| Interest Expense | 1.1M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 991K | 897K |
| Depreciation And Amortization | 5K | 0 | 5K | 15K | 1K | 1K | 1K | 2K |
| Ebitda | -80.5M | -69.3M | -69.6M | -68.8M | -71.5M | -54.8M | -52.4M | -54.3M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -81.6M | -70.5M | -70.7M | -70.0M | -72.7M | -56.0M | -53.3M | -55.2M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 | -0.81 | -0.90 | -0.99 |
| Weighted Average Shs Out | 82.0M | 81.7M | 78.7M | 70.6M | 69.4M | 69.2M | 59.3M | 55.7M |
| Weighted Average Shs Out Dil | 82.0M | 81.7M | 78.7M | 70.6M | 69.4M | 69.2M | 59.3M | 55.7M |